Patents Assigned to SANTA CRUZ BIOTECHNOLOGY, INC.
  • Recombinant VapA and VapC peptides and uses thereof
    Patent number: 9926342
    Abstract: The present invention provides a recombinant protein comprising consecutive amino acids, the sequence of which is substantially identical to a sequence of amino acids present in a Rhodococcus equi virulence-associated protein and compositions containing fusion proteins of the invention. The present invention also provides uses of the compositions in the manufacture of hyperimmune plasma against Rhodococcus equi, in producing a hyperimmune plasma against Rhodococcus equi in protecting an animal against Rhodococcus equi and in protecting a newborn animal against Rhodococcus equi.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: March 27, 2018
    Assignee: SANTA CRUZ BIOTECHNOLOGY, INC.
    Inventor: John R. Stephenson
  • RECOMBINANT VAPA AND VAPC PEPTIDES AND USES THEREOF
    Publication number: 20150023983
    Abstract: The present invention provides a recombinant protein comprising consecutive amino acids, the sequence of which is substantially identical to a sequence of amino acids present in a Rhodococcus equi virulence-associated protein and compositions containing fusion proteins of the invention. The present invention also provides uses of the compositions in the manufacture of hyperimmune plasma against Rhodococcus equi, in producing a hyperimmune plasma against Rhodococcus equi in protecting an animal against Rhodococcus equi and in protecting a newborn animal against Rhodococcus equi.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 22, 2015
    Applicant: SANTA CRUZ BIOTECHNOLOGY, INC.
    Inventor: John R. Stephenson